Inventor

MASCAGNI PAOLO

IT21 patents

⚠️ This page may combine multiple inventors who share the name “MASCAGNI PAOLO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MASCAGNI PAOLO

ITALFARMACO SPA

Sustained release pharmaceutical compositions for the parenteral administration of hydrophilic compounds

Oligopeptides derived from C-reactive protein fragments

Compounds with anti-inflammatory and immunosuppressive activities

Analogues of the active metabolite of leflunomide

Monohydrate hydrochloride of the 4-hydroxycarbamoyl-phenyl)-carbamic acid (6-diethylaminomethyl-naphtalen-2-yl) ester

Oligopeptides derived from C-reactive protein fragments

Alpha-amino acid derivatives with antiinflammatory activity

Complexes of paroxetine, with cyclodextrins or cyclodextrin derivatives

Hydroxamic acid derivatives having anti-inflammatory action

Peptides endowed with antiinflammatory activity

Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chloride for use in the treatment of muscular dystrophy

Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chloride for use in the treatment of muscular dystrophy

Physically and chemically stable oral suspensions of givinostat

Use of histone deacetylase inhibitors for the care of philadelphia-negative myeloproliferative syndromes

Azole derivative useful as antifungal agents with reduced interaction with metabolic cytochromes

Benzo-N-hydroxy amide compounds having antitumor activity

ARTICO ROBERTA

Riluzole aqueous suspensions

DINARELLO CHARLES

Derivatives of N-hydroxybenzamide for treating HIV infections

LEONI FLAVIO

Use of hydroxamic acid derivatives for the preparation of anti-tumour medicaments

VITALI ANDREA

Non-selective somatostatin analogues

MASCAGNI PAOLO

Method for treating Philadelphia-negative myeloproliferative syndromes